Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
暂无分享,去创建一个
W. Klunk | C. Mathis | J. Price | H. Engler | A. Nordberg | Yanming Wang | G. Blomqvist | D. Holt | M. Bergström | I. Savitcheva | Guo-feng Huang | S. Estrada | Birgitta Ausén | M. Debnath | J. Barletta | J. Sandell | B. Lopresti | A. Wall | P. Koivisto | G. Antoni | B. Långström | J. Price | J. Price
[1] Albert Gjedde,et al. High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain , 1981, Journal of neurochemistry.
[2] G. Glenner. Alzheimer's disease. The commonest form of amyloidosis. , 1983, Archives of pathology & laboratory medicine.
[3] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] Glenner Gg. Alzheimer's disease. The commonest form of amyloidosis. , 1983, Archives of pathology & laboratory medicine.
[5] R H Huesman,et al. Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.
[6] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[7] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] M J Campbell,et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[9] D. Selkoe,et al. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. , 1989, The American journal of pathology.
[10] H. Braak,et al. Alzheimer's Disease: Striatal Amyloid Deposits and Neurofibrillary Changes , 1990, Journal of neuropathology and experimental neurology.
[11] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] G. V. Van Hoesen,et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.
[13] J. Pettegrew,et al. Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease , 1994, Neurobiology of Aging.
[14] D. Newport,et al. Evaluation of simulation-based scatter correction for 3-D PET cardiac imaging , 1995 .
[15] M.E. Casey,et al. Evaluation of simulation-based scatter correction for 3D PET cardiac imaging , 1995, 1995 IEEE Nuclear Science Symposium and Medical Imaging Conference Record.
[16] J C Mazziotta,et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.
[17] Richard S. J. Frackowiak,et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease , 1995, Neuroscience Letters.
[18] W. März,et al. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation , 1995, Neuroscience.
[19] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] J. Price,et al. Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.
[21] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[22] R. Elble,et al. The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease. , 1997, Neuropathology and applied neurobiology.
[23] L. Thurfjell,et al. Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans. , 1997, Journal of computer assisted tomography.
[24] Rodger J. Elble,et al. The distribution of amyloid β protein deposition in the corpus striatum of patients with Alzheimer's disease , 1997 .
[25] T. Lehtimäki,et al. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains , 1997, Neurobiology of Aging.
[26] P. Hedera,et al. Neuroimaging of Vessel Amyloid in Alzheimer's Disease a, b , 1997, Annals of the New York Academy of Sciences.
[27] J. Price,et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.
[28] P. Lansbury,et al. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. , 1999, Journal of medicinal chemistry.
[29] M. Shigeta,et al. A Follow-Up Study of the Family with the Swedish APP 670/671 Alzheimer’s Disease Mutation , 1999, Dementia and Geriatric Cognitive Disorders.
[30] G. Bormans,et al. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer’s disease , 1999, European Journal of Nuclear Medicine.
[31] W. Markesbery,et al. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. , 1999, Alzheimer disease and associated disorders.
[32] G. Curran,et al. Targeting Alzheimer amyloid plaques in vivo , 2000, Nature Biotechnology.
[33] V. Jelic,et al. Early Diagnosis of Alzheimer Disease With Positron Emission Tomography , 2000, Alzheimer disease and associated disorders.
[34] W. Klunk,et al. X-34, A Fluorescent Derivative of Congo Red: A Novel Histochemical Stain for Alzheimer's Disease Pathology , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[35] H. Matsuda. Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease , 2001, Annals of nuclear medicine.
[36] J. Price,et al. Absence of cognitive impairment or decline in preclinical Alzheimer’s disease , 2001, Neurology.
[37] G. Small,et al. Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease , 2001, The Journal of Neuroscience.
[38] W. Klunk,et al. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. , 2001, Life sciences.
[39] J. Trojanowski,et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. , 2001, Journal of medicinal chemistry.
[40] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[41] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[42] Brian J Bacskai,et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.
[43] H. Engler,et al. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[44] G. Alexander,et al. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.
[45] W. Klunk,et al. Synthesis and evaluation of 2-(3′-lodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in alzheimer’s disease , 2002, Journal of Molecular Neuroscience.
[46] G. Small,et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[47] Brian J Bacskai,et al. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] William E. Klunk,et al. The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component , 2003, The Journal of Neuroscience.
[49] W. Klunk,et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.
[50] Bengt Långström,et al. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development , 2003, European Journal of Clinical Pharmacology.
[51] A. Hirano,et al. Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease , 2004, Acta Neuropathologica.
[52] S. Hirai,et al. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated byβ protein immunostain , 2004, Acta Neuropathologica.
[53] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.